Time again for our #ImageOfTheWeek! This week’s image is a CD138 Expression in Inflammatory Bone Marrow! This protocol is used to detect plasma cells in bone marrow samples in Phase 1, Phase 1/2, and Phase 2 clinical studies. Thanks to Alexy Promonet for creating this image! Want to discover more? You can already have a sneak peek at our Art of Histopathology book: https://lnkd.in/emRtqNGV #TransformingResearch #AdvancingHealth #Histopathology #IHC
Cerba Research
Biotechnology Research
Ghent, Flemish Region 12,771 followers
Transforming Research, Advancing Health Together
About us
At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation of human-centric healthcare, by transforming research, and advancing health together. Uniquely, we combine the experience of specialty laboratories with the global reach of a central lab. We have a worldwide network of 1000 labs, hold data from over 85 million patients across five continents, and have the ability to sequence 1000-plus whole human genomes per week. This unparalleled approach to patient data gives you the opportunity to have one partner for all your test services, with consistent access and support across all clinical trial phases.
- Website
-
http://www.cerbaresearch.com
External link for Cerba Research
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Ghent, Flemish Region
- Type
- Privately Held
Locations
Employees at Cerba Research
Updates
-
Discover Cerba Research Canada! Formerly known as CIRION BioPharma, our Canadian lab is highly recognized for its integrated bioanalytical and global central laboratory services. With extensive experience in supporting biologics and biosimilar drug development for market authorization in non-clinical and clinical studies, Cerba Research Canada is your trusted and agile laboratory partner for the bioanalytical space. Visit our website to learn more about our expertise and how we can support your research needs: https://lnkd.in/e25tuUEa
-
Did you know Cerba Research's in-house semi-automated kit-building line can produce up to 700 kits daily? Our guarantee on kits produced to the highest quality levels ensures we can support the most complex to routine sample kit build and support your clinical trial sites. Read more here: https://lnkd.in/e4fxqG9C #TransformingResearch #AdvancingHealth #clinicaltrials #kitbuilding
-
#ImageOfTheWeek is back! This week, we have a p16 expression in Uterine Leiomyosarcoma. This protocol was validated at a secondary endpoint level. This marker is used to diagnose the human papillomavirus (HPV). Want to discover more? You can already have a sneak peek at our Art of Histopathology book: https://lnkd.in/e6wmUJyj #ImageOfTheWeek #P16 #IHC #HPV #Histopathology
-
Happy 4th of July from Cerba Research!! 🎆 We hope you had a fantastic Independence Day filled with joy, pride, and memorable moments with loved ones. As we continue to celebrate the spirit of freedom, we extend our heartfelt thanks to all our clients and partners in the USA for being a valued part of our journey to transforming research and advancing health. #IndependenceDay #4thOfJuly #CerbaResearch #TransformningResearch #AdvacingHealth
-
Cerba Research reposted this
Cerba HealthCare unveils its 2023/2024 CSR report. The Group stays on course and on its #CSR trajectory with progress on 2 flagship indicators: 👉 #Social: 41% of #women 👩🏻💼 present on the CODIR. The Group has set itself a target of 45% women among the 210 members of management committees in the Group's various subsidiaries by 2028. 👉 #Environment: -18% reduction in absolute #CO2 emissions on scopes 1 and 2 (direct emissions such as electricity, gas and fuel) compared with last year. The objective by 2030 is to achieve a -42% reduction in CO2 emissions. Consult the CSR report: https://loom.ly/DTRq344
-
Did you know that Cerba Research is present in Africa and, thanks to Cerba Lancet, supported by a network of 11 African countries? With our experience in delivering high-quality PBMC isolation, we enable precise and reliable data, which is critical for clinical trials across the continent—dedicated to the development of innovative compounds. Our central and specialty laboratory services also provide for all of your clinical trial requirements. From the first sample collection to the final analysis, we are dedicated to delivering excellence and accuracy at every stage. Let us work together to accelerate development and improve health outcomes in Africa! Discover more: https://lnkd.in/egecVQAC
-
Take a tour of our US central & specialty laboratory, with in-house kit build and design - our kits contain everything you need to keep sites running #TransformingResearch #AdvancingHealth
-
During the The World Vaccine Congress 2024, Cerba Research was part of a roundtable discussion with other key companies discussing Infectious Disease Clinical Trials: Navigating Innovation and Rising Complexity. The panelists Grace L Chen Phillips, nele langenaken, Trina Racine, John Rex, Chijioke Bennett. MD, MPH, MBA, Roxana Rustomjee, MBChB, FCPHM, MMed, PhD and Janelle Hart discussed the evolving landscape for infectious disease clinical trials, the operational barriers for therapeutics and vaccine development, and why improving epidemiologic surveillance and communication are critical to strengthening site and patient enrolment in clinical trials. You can check the report here: https://lnkd.in/duXbAVsC #TransformingResearch #AdvancingHealth #VaccineDevelopment #InfectiousDiseases #VaccineLab
-
Did you know that we work with CROs as well as directly with sponsors? In fact, they account for over 30% of our partnerships. We manage complex laboratory requirements across multiple countries and sites, supported by scientific teams, experienced project managers and a global logistical framework. By partnering with project teams to deliver data we enable sponsors to make clearer, more patient-focused decisions. Let’s transform your clinical research: https://lnkd.in/efqjZZXT #ClinicalResearch #OurCollectiveFocus